gfh375
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Jul 9, 2024 (NCT06500676)
Timeline
Indications
Mechanism of action
- GTPase KRasINHIBITOR
KRAS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07262567 | Phase 3 | Dec 31, 2025 | Zhejiang Genfleet Therapeutics Co., Ltd. |
| NCT07259590 | Phase 1/Phase 2 (Phase 2) | Oct 21, 2025 | Peking University, Zhejiang Genfleet Therapeutics Co., Ltd. |
| NCT07026916 | Phase 2 | Aug 31, 2025 | Zhejiang Genfleet Therapeutics Co., Ltd. |
| NCT06500676 | Phase 1/Phase 2 (Phase 2) | Jul 9, 2024 | Jiao Tong University, Zhejiang Genfleet Therapeutics Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Genfleet Therapeutics Co., Ltd. | For profit | 4 | 4 | 2 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1